Quick Hits

• The DOJ ordered the reclassification of certain marijuana and marijuana-containing products from Schedule I to Schedule III controlled substances, potentially reshaping medical research and employer policies around its use. 
• Reclassification could lead to more medical research on marijuana and other non-employment-related impacts.
• Reclassification could also have implications for employers, including the handling of

…